Willowcroft Health

WHC50H inhibits the formation, growth and metastasis of solid tumors of Pancreatic Cancer. WHC50H is non-toxic, no side effects and non-resistant.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Denver, CO, USA
  • Currency USD
  • Founded February 2018
  • Employees 2
  • Incorporation Type C-corp
  • Website Willowcrofthealth.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free